Foghorn Therapeutics (FHTX) Assets (2020 - 2025)
Historic Assets for Foghorn Therapeutics (FHTX) over the last 6 years, with Q3 2025 value amounting to $205.0 million.
- Foghorn Therapeutics' Assets fell 3353.42% to $205.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $205.0 million, marking a year-over-year decrease of 3353.42%. This contributed to the annual value of $284.0 million for FY2024, which is 67.64% down from last year.
- Latest data reveals that Foghorn Therapeutics reported Assets of $205.0 million as of Q3 2025, which was down 3353.42% from $226.2 million recorded in Q2 2025.
- In the past 5 years, Foghorn Therapeutics' Assets registered a high of $519.8 million during Q4 2021, and its lowest value of $186.1 million during Q3 2021.
- For the 5-year period, Foghorn Therapeutics' Assets averaged around $321.4 million, with its median value being $308.4 million (2024).
- As far as peak fluctuations go, Foghorn Therapeutics' Assets surged by 13321.03% in 2022, and later crashed by 3353.42% in 2025.
- Over the past 5 years, Foghorn Therapeutics' Assets (Quarter) stood at $519.8 million in 2021, then decreased by 22.1% to $404.9 million in 2022, then fell by 29.38% to $285.9 million in 2023, then fell by 0.68% to $284.0 million in 2024, then decreased by 27.83% to $205.0 million in 2025.
- Its last three reported values are $205.0 million in Q3 2025, $226.2 million for Q2 2025, and $258.7 million during Q1 2025.